Development and evaluation of pharmacological agents targeting chemokine receptors
- 23 April 2003
- Vol. 29 (4) , 369-375
- https://doi.org/10.1016/s1046-2023(02)00361-4
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- α1-Adrenoceptor Antagonists. 4. Pharmacophore-Based Design, Synthesis, and Biological Evaluation of New Imidazo-, Benzimidazo-, and Indoloarylpiperazine DerivativesJournal of Medicinal Chemistry, 2002
- Synthesis and Pharmacological Evaluation of 5-(4-Biphenyl)-3-methyl-4-phenyl-1,2,4-triazole Derivatives as a Novel Class of Selective Antagonists for the Human Vasopressin V1A ReceptorJournal of Medicinal Chemistry, 2002
- Chemokine receptorsCytokine & Growth Factor Reviews, 2001
- A Non-peptide Functional Antagonist of the CCR1 Chemokine Receptor Is Effective in Rat Heart Transplant RejectionPublished by Elsevier ,2001
- Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor AntagonistsPublished by Elsevier ,2000
- Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejectionJournal of Clinical Investigation, 2000
- Association of CCR5 ▵32 with reduced risk of asthmaThe Lancet, 1999
- Chemokine-receptor polymorphisms: clarity or confusion for HIV-1 prognosis?The Lancet, 1998
- Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 InfectionCell, 1996
- A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonistsNature, 1993